Latham & Watkins LLP represented the underwriters and placements agents in the transaction.Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, has announced the…
Vor Biopharma’s $115.8 Million Common Stock Offering and Private Placement
